FDA Approved: OXCARBAZEPINE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Oxcarbazepine by NorthStar RxLLC (ANDA216749).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)